Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001300699-15-000001
Filing Date
2015-05-20
Accepted
2015-05-20 15:23:27
Documents
1
Effectiveness Date
2015-05-20
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7747
  Complete submission text file 0001300699-15-000001.txt   8865
Mailing Address 701 ELLICOTT STREET BUFFALO NY 14203
Business Address 701 ELLICOTT STREET BUFFALO NY 14203 716-898-8625
Kinex Pharmaceuticals, Inc. (Filer) CIK: 0001300699 (see all company filings)

EIN.: 431985966 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-240276 | Film No.: 15879420